Dr. Evie Carchman | Cancer prevention | Best Researcher Award 

Associate Professor | University of Wisconsin | United States

Dr. Evie H. Carchman is a distinguished clinician-scientist affiliated with the William S. Middleton Memorial Veterans Hospital in Madison, United States, recognized for her extensive contributions to colorectal and anal disease research. With 68 publications and over 3,700 citations. Dr. Carchman’s work has significantly advanced understanding in areas such as anal cancer prevention, dysplasia detection, and surgical innovation. Her studies on PIK3CA mutations in anal dysplasia, peristaltic contractility in ileal pouch-anal anastomosis (IPAA), and CD4/CD8 ratio as a biomarker in veterans with HIV highlight her multidisciplinary approach that bridges oncology, immunology, and gastrointestinal surgery. As an author and collaborator with over 3,000 co-researchers worldwide, she exemplifies scientific collaboration aimed at improving patient outcomes and translational medicine. Dr. Carchman’s recent publications in reputed journals such as the International Journal of Colorectal Disease, Scientific Reports, and Diseases of the Colon and Rectum emphasize her leadership in identifying novel therapeutic sensitivities in cancer organoids and exploring minimally invasive treatments, including laser hair removal as a primary therapy for pilonidal disease. Her dedication to veterans’ healthcare and public health innovation underscores a career defined by scientific rigor, compassion, and commitment to advancing surgical science and cancer prevention. Through her impactful research, mentorship, and international collaborations, Dr. Evie H. Carchman continues to shape the global landscape of colorectal oncology and preventive medicine, contributing meaningfully to both academic excellence and societal well-being.

Profiles: Scopus | ORCID 

Featured Publications

1. Johnson, H. R., Dietmann, E. C., Praska, C. E., Dennison, K. L., McGregor, S. M., Suter, W., Leverson, G., Murtaza, M., & Carchman, E. H. (2025, November). Detection of PIK3CA mutations in anal dysplasia. Journal of Surgical Research. Advance online publication.

2. Hewitt, A. J., Freeman, M. J., Hayden, D. M., Carchman, E. H., Schweizer, M. L., & Sanger, C. B. (2025, November). Evaluation of anal cancer screening practices among a national cohort of veterans with HIV. Diseases of the Colon & Rectum. Advance online publication.

3. DeZeeuw, A. K., Bassetti, M. F., Carchman, E. H., Heise, C. P., Hayden, D., Lawson, E. H., Sanger, C. B., King, R., LoConte, N. K., Lubner, S. J., et al. (2024, September 3). Carboplatin and paclitaxel chemoradiation for localized anal cancer in patients not eligible for mitomycin and 5-fluorouracil. Cancers, 16(17), 3062. 
Cited by: 1

4. Lozar, T., Wang, W., Gavrielatou, N., Christensen, L., Lambert, P. F., Harari, P. M., Rimm, D. L., Burtness, B., Grasic Kuhar, C., & Carchman, E. H. (2023, November 25). Emerging prognostic and predictive significance of stress keratin 17 in HPV-associated and non HPV-associated human cancers: A scoping review. Viruses, 15(12), 2320. 
Cited by: 4

Dr. Evie H. Carchman’s pioneering research in colorectal and anal cancer prevention integrates molecular oncology, surgical innovation, and translational science to improve patient outcomes. Her work advances global cancer prevention strategies through early detection, precision medicine, and evidence-based clinical practice.

Evie Carchman | Cancer Prevention | Best Researcher Award

You May Also Like